BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25853860)

  • 1. Immunophenotyping of Waldenströms macroglobulinemia cell lines reveals distinct patterns of surface antigen expression: potential biological and therapeutic implications.
    Paulus A; Chitta KS; Wallace PK; Advani PP; Akhtar S; Kuranz-Blake M; Ailawadhi S; Chanan-Khan AA
    PLoS One; 2015; 10(4):e0122338. PubMed ID: 25853860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and characterization of a novel Waldenstrom macroglobulinemia cell line, MWCL-1.
    Hodge LS; Novak AJ; Grote DM; Braggio E; Ketterling RP; Manske MK; Price Troska TL; Ziesmer SC; Fonseca R; Witzig TE; Morice WG; Gertz MA; Ansell SM
    Blood; 2011 May; 117(19):e190-7. PubMed ID: 21415268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and characterization of a novel human Waldenström macroglobulinemia cell line: RPCI-WM1, Roswell Park Cancer Institute - Waldenström Macroglobulinemia 1.
    Chitta KS; Paulus A; Ailawadhi S; Foster BA; Moser MT; Starostik P; Masood A; Sher T; Miller KC; Iancu DM; Conroy J; Nowak NJ; Sait SN; Personett DA; Coleman M; Furman RR; Martin P; Ansell SM; Lee K; Chanan-Khan AA
    Leuk Lymphoma; 2013 Feb; 54(2):387-96. PubMed ID: 22812491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunophenotypic profile of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia.
    Konoplev S; Medeiros LJ; Bueso-Ramos CE; Jorgensen JL; Lin P
    Am J Clin Pathol; 2005 Sep; 124(3):414-20. PubMed ID: 16191510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Despite apparent morphologic and immunophenotypic heterogeneity, Waldenstrom's macroglobulinemia is consistently composed of cells along a morphologic continuum of small lymphocytes, plasmacytoid lymphocytes, and plasma cells.
    Remstein ED; Hanson CA; Kyle RA; Hodnefield JM; Kurtin PJ
    Semin Oncol; 2003 Apr; 30(2):182-6. PubMed ID: 12720133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunophenotypic analysis of Waldenstrom's macroglobulinemia.
    San Miguel JF; Vidriales MB; Ocio E; Mateo G; Sánchez-Guijo F; Sánchez ML; Escribano L; Bárez A; Moro MJ; Hernández J; Aguilera C; Cuello R; García-Frade J; López R; Portero J; Orfao A
    Semin Oncol; 2003 Apr; 30(2):187-95. PubMed ID: 12720134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant hematopoietic cell lines: in vitro models for the study of Waldenström's macroglobulinemia.
    Drexler HG; MacLeod RA
    Leuk Res; 2008 Nov; 32(11):1669-73. PubMed ID: 18533260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunophenotypic and cytogenetic comparison of Waldenstrom's macroglobulinemia with splenic marginal zone lymphoma.
    Ocio EM; Hernandez JM; Mateo G; Sanchez ML; Gonzalez B; Vidriales B; Gutierrez NC; Orfao A; San Miguel JF
    Clin Lymphoma; 2005 Mar; 5(4):241-5. PubMed ID: 15794856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of serotherapy target antigens in Waldenstrom's macroglobulinemia: therapeutic applications and considerations.
    Treon SP; Kelliher A; Keele B; Frankel S; Emmanouilides C; Kimby E; Schlossman R; Mitsiades N; Mitsiades C; Preffer F; Anderson KC
    Semin Oncol; 2003 Apr; 30(2):248-52. PubMed ID: 12720146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometric immunophenotyping analysis of patterns of antigen expression in non-Hodgkin's B cell lymphoma in samples obtained from different anatomic sites.
    Gervasi F; Lo Verso R; Giambanco C; Cardinale G; Tomaselli C; Pagnucco G
    Ann N Y Acad Sci; 2004 Dec; 1028():457-62. PubMed ID: 15650271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Origin of Waldenstrom's macroglobulinaemia.
    García-Sanz R; Jiménez C; Puig N; Paiva B; Gutiérrez NC; Rodríguez-Otero P; Almeida J; San Miguel J; Orfão A; González M; Pérez-Andrés M
    Best Pract Res Clin Haematol; 2016 Jun; 29(2):136-147. PubMed ID: 27825459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of BCWM.1 cell line for Waldenström's macroglobulinemia with productive in vivo engraftment in SCID-hu mice.
    Ditzel Santos D; Ho AW; Tournilhac O; Hatjiharissi E; Leleu X; Xu L; Tassone P; Neri P; Hunter ZR; Chemaly MA; Branagan AR; Manning RJ; Patterson CJ; Moreau AS; Ciccarelli B; Adamia S; Kriangkum J; Kutok JL; Tai YT; Zhang J; Pilarski LM; Anderson KC; Munshi N; Treon SP
    Exp Hematol; 2007 Sep; 35(9):1366-75. PubMed ID: 17761288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developing diagnostic criteria in Waldenstrom's macroglobulinemia.
    Owen RG
    Semin Oncol; 2003 Apr; 30(2):196-200. PubMed ID: 12720135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of subpopulation lacking both B-cell and plasma cell markers in Waldenstrom macroglobulinemia cell line.
    Wada N; Zhan M; Hori Y; Honma K; Ikeda J; Morii E
    Lab Invest; 2014 Jan; 94(1):79-88. PubMed ID: 24189269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Waldenström macroglobulinemia. Development of diagnostic criteria and identification of prognostic factors.
    Owen RG; Barrans SL; Richards SJ; O'Connor SJ; Child JA; Parapia LA; Morgan GJ; Jack AS
    Am J Clin Pathol; 2001 Sep; 116(3):420-8. PubMed ID: 11554171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgM myeloma: case report with immunophenotypic profile.
    Haghighi B; Yanagihara R; Cornbleet PJ
    Am J Hematol; 1998 Dec; 59(4):302-8. PubMed ID: 9840911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD5, CD10, and CD23 expression in Waldenstrom's macroglobulinemia.
    Hunter ZR; Branagan AR; Manning R; Patterson CJ; Santos DD; Tournilhac O; Dorfman DM; Treon SP
    Clin Lymphoma; 2005 Mar; 5(4):246-9. PubMed ID: 15794857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transitions in CD45 isoform expression indicate continuous differentiation of a monoclonal CD5+ CD11b+ B lineage in Waldenstrom's macroglobulinemia.
    Jensen GS; Andrews EJ; Mant MJ; Vergidis R; Ledbetter JA; Pilarski LM
    Am J Hematol; 1991 May; 37(1):20-30. PubMed ID: 1708944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical phenotyping of plasma cells in lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia is comparable to flow cytometric techniques.
    Howard MT; Hodnefield J; Morice WG
    Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):96-8. PubMed ID: 21454202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene Expression Profiling Reveals Aberrant T-cell Marker Expression on Tumor Cells of Waldenström's Macroglobulinemia.
    Hao M; Barlogie B; Tricot G; Liu L; Qiu L; Shaughnessy JD; Zhan F
    Clin Cancer Res; 2019 Jan; 25(1):201-209. PubMed ID: 30279229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.